The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
The Pseudokinase Domain Is Required for Suppression of Basal Activity of Jak2 and Jak3 Tyrosine Kinases and for Cytokine-inducible Activation of Signal Transduction
Open accessAbstract
Janus (Jak) tyrosine kinases contain a tyrosine kinase (JH1) domain adjacent to a catalytically inactive pseudokinase domain (JH2). The JH2 domain has been implicated in regulation of Jak activity, but its function remains poorly understood. Here, we found that the JH2 domain negatively regulates the activity of Jak2 and Jak3. Deletion of JH2 resulted in increased tyrosine phosphorylation of the Jak2- and Jak3-JH2 deletion mutants as well as of coexpressed STAT5. In cytokine receptor signaling, the deletion of the Jak2- and Jak3-JH2 domains resulted in interferon-gamma and interleukin-2-independent STAT activation, respectively. However, cytokine stimulations did not further induce the JH2 deletion mutant-mediated STAT activation. The deletion of the Jak2 JH2 domain also abolished interferon-gamma-inducible kinase activation, although it did not affect the reciprocal Jak1-Jak2 interaction in 293T cells. Chimeric constructs, where the JH2 domains were swapped between Jak2 and Jak3, retained low basal activity and cytokine inducible signaling, indicating functional conservation between the two JH2 domains. However, the basal activity of Jak2 was significantly lower than that of Jak3, suggesting differences in the regulation of Jak2 and Jak3 activity. In conclusion, we found that the JH2 domain has a conserved function in Jak2 and Jak3. The JH2 domain is required for two distinct functions in cytokine signaling: (i) inhibition of the basal activity of Jak2 and Jak3, and (ii) cytokine-inducible activation of signaling. The Jak-JH2 deletion mutants are catalytically active, activate STAT5, and interact with another Jak kinase, but the JH2 domain is required to connect these signaling events to receptor activation. Thus, we propose that the JH2 domain contributes to both the uninduced and ligand-induced Jak-receptor complex, where it acts as a cytokine-inducible switch to regulate signal transduction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Darnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
SMART, a simple modular architecture research tool: Identification of signaling domains
Schultz, J., Milpetz, F., Bork, P., & Ponting, C. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.5857 · Cited by 3,599
JAKS AND STATS: Biological Implications
Leonard, W. J., & O'Shea, J. J. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.293 · Cited by 1,804
[22] Using CLUSTAL for multiple sequence alignments
Higgins, D. G., Thompson, J. D., & Gibson, T. J. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)66024-8 · Cited by 1,571
Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors
Parganas, E., Wang, D., Stravopodis, D., Topham, D. J., Marine, J.-C., Teglund, S., Vanin, E. F., Bodner, S., Colamonici, O. R., van Deursen, J. M., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81167-8 · Cited by 1,156
Jak2 Deficiency Defines an EssentialDevelopmental Checkpoint in DefinitiveHematopoiesis
Neubauer, H., Cumano, A., Müller, M., Wu, H., Huffstadt, U., & Pfeffer, K. (1998) · Cell · doi:10.1016/s0092-8674(00)81168-x · Cited by 914
Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
Macchi, P., Villa, A., Giliani, S., Sacco, M. G., Frattini, A., Porta, F., Ugazio, A. G., Johnston, J. A., Candotti, F., O'Sheai, J. J., et al. (1995) · Nature · doi:10.1038/377065a0 · Cited by 877
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
Russell, S. M., Tayebi, N., Nakajima, H., Riedy, M. C., Roberts, J. L., Aman, M. J., Migone, T.-S., Noguchi, M., Markert, M. L., Buckley, R. H., et al. (1995) · Science · doi:10.1126/science.270.5237.797 · Cited by 803
Yasukawa, H., Misawa, H., Sakamoto, H., Masuhara, M., Sasaki, A., Wakioka, T., Ohtsuka, S., Imaizumi, T., Matsuda, T., Ihle, J. N., et al. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1309 · Cited by 719
Defective Lymphoid Development in Mice Lacking Jak3
Nosaka, T., van Deursen, J. M. A., Tripp, R. A., Thierfelder, W. E., Witthuhn, B. A., McMickle, A. P., Doherty, P. C., Grosveld, G. C., & Ihle, J. N. (1995) · Science · doi:10.1126/science.270.5237.800 · Cited by 637
Witthuhn, B. A., Silvennoinen, O., Miura, O., Lai, K. S., Cwik, C., Liu, E. T., & Ihle, J. N. (1994) · Nature · doi:10.1038/370153a0 · Cited by 613
Self-citationSignaling Through the Hematopoietic Cytokine Receptors
Ihle, J. N. (1995) · Annual Review of Immunology · doi:10.1146/annurev.immunol.13.1.369 · Cited by 612
Functional Activation of Jak1 and Jak3 by Selective Association with IL-2 Receptor Subunits
Miyazaki, T., Kawahara, A., Fujii, H., Nakagawa, Y., Minami, Y., Liu, Z.-J., Oishi, I., Silvennoinen, O., Witthuhn, B. A., Ihle, J. N., et al. (1994) · Science · doi:10.1126/science.7973659 · Cited by 589
Self-citationGouilleux, F., Wakao, H., Mundt, M., & Groner, B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06756.x · Cited by 588
Defects in B Lymphocyte Maturation and T Lymphocyte Activation in Mice Lacking Jak3
Thomis, D. C., Gurniak, C. B., Tivol, E., Sharpe, A. H., & Berg, L. J. (1995) · Science · doi:10.1126/science.270.5237.794 · Cited by 537
Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B. A., Quelle, F. W., Rogers, N. C., Schindler, C., Stark, G. R., Ihle, J. N., et al. (1993) · Nature · doi:10.1038/366166a0 · Cited by 533
Self-citationSilvennoinen, O., Witthuhn, B. A., Quelle, F. W., Cleveland, J. L., Yi, T., & Ihle, J. N. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8429 · Cited by 501
Self-citationTYK2 and JAK2 Are Substrates of Protein-tyrosine Phosphatase 1B
Myers, M. P., Andersen, J. N., Cheng, A., Tremblay, M. L., Horvath, C. M., Parisien, J.-P., Salmeen, A., Barford, D., & Tonks, N. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100583200 · Cited by 474
Sasaki, A., Yasukawa, H., Suzuki, A., Kamizono, S., Syoda, T., Kinjyo, I., Sasaki, M., Johnston, J. A., & Yoshimura, A. (1999) · Genes to Cells · doi:10.1046/j.1365-2443.1999.00263.x · Cited by 398
Regulation of the Jak2 Tyrosine Kinase by Its Pseudokinase Domain
Saharinen, P., Takaluoma, K., & Silvennoinen, O. (2000) · Molecular and Cellular Biology · doi:10.1128/.20.10.3387-3395.2000 · Cited by 365
Self-citationFeng, J., Witthuhn, B. A., Matsuda, T., Kohlhuber, F., Kerr, I. M., & Ihle, J. N. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.5.2497 · Cited by 356
The T Cell Protein Tyrosine Phosphatase Is a Negative Regulator of Janus Family Kinases 1 and 3
Simoncic, P. D., Lee-Loy, A., Barber, D. L., Tremblay, M. L., & McGlade, C. J. (2002) · Current Biology · doi:10.1016/s0960-9822(02)00697-8 · Cited by 351
Pine, R., Canova, A., & Schindler, C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06245.x · Cited by 347
Huang, L. J.-S., Constantinescu, S. N., & Lodish, H. F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00401-4 · Cited by 294
Ungureanu, D., Saharinen, P., Junttila, I., Hilton, D. J., & Silvennoinen, O. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.10.3316-3326.2002 · Cited by 260
Self-citationMutation in the Jak Kinase JH2 Domain Hyperactivates Drosophila and Mammalian Jak-Stat Pathways
Luo, H., Rose, P., Barber, D., Hanratty, W. P., Lee, S., Roberts, T. M., D’Andrea, A. D., & Dearolf, C. R. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1562 · Cited by 242
A JAK1/JAK2 Chimera Can Sustain Alpha and Gamma Interferon Responses
Kohlhuber, F. K., Rogers, N. C., Watling, D., Feng, J., Guschin, D., Briscoe, J., Witthuhn, B. A., Kotenko, S. V., Pestka, S., Stark, G. R., et al. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.2.695 · Cited by 218
The state of the STATs: recent developments in the study of signal transduction to the nucleus
Horvath, C. M., & Darnell, J. E. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80067-1 · Cited by 204
Constantinescu, S. N., Huang, L. J.-S., Nam, H.-S., & Lodish, H. F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00185-x · Cited by 178
The N-termini of FAK and JAKs contain divergent band 4.1 domains
Girault, J.-A., Labesse, G., Mornon, J.-P., & Callebaut, I. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01331-0 · Cited by 168
Velazquez, L., Mogensen, K. E., Barbieri, G., Fellous, M., Uzé, G., & Pellegrini, S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3327 · Cited by 161
Chen, M., Cheng, A., Candotti, F., Zhou, Y.-J., Hymel, A., Fasth, A. L., Notarangelo, L. D., & O’Shea, J. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.947-956.2000 · Cited by 152
Unexpected Effects of FERM Domain Mutations on Catalytic Activity of Jak3
Zhou, Y., Chen, M., Cusack, N., Kimmel, L. H., Magnuson, K. S., Boyd, J. G., Lin, W., Roberts, J. L., Lengi, A. J., Buckley, R. H., et al. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00398-7 · Cited by 143
Structural and Functional Basis for JAK3-Deficient Severe Combined Immunodeficiency
Candotti, F., Oakes, S. A., Johnston, J. A., Giliani, S., Schumacher, R. F., Mella, P., Fiorini, M., Ugazio, A. G., Badolato, R., Notarangelo, L. D., et al. (1997) · Blood · doi:10.1182/blood.v90.10.3996 · Cited by 142
Saito, K., Scharenberg, A. M., & Kinet, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100873200 · Cited by 140
Gauzzi, M. C., Barbieri, G., Richter, M. F., Uzé, G., Ling, L. E., Fellous, M., & Pellegrini, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.11839 · Cited by 130
Zhou, Y., Hanson, E. P., Chen, Y., Magnuson, K. S., Chen, M., Swann, P. G., Wange, R. L., Changelian, P. S., & O’Shea, J. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13850 · Cited by 125
Oakes, S. A., Candotti, F., Johnston, J. A., Chen, Y., RYAN, J., Taylor, N. N., Liu, X., Hennighausen, L. G., Notarangelo, L. D., Paul, W. E., et al. (1996) · Immunity · doi:10.1016/s1074-7613(00)80274-5 · Cited by 125
JAK protein tyrosine kinases: their role in cytokine signalling
Ziemiecki, A., Harpur, A. G., & Wilks, A. F. (1994) · Trends in Cell Biology · doi:10.1016/0962-8924(94)90143-0 · Cited by 121
Saharinen, P., Ekman, N., Sarvas, K., Parker, P. J., Alitalo, K. K., & Silvennoinen, O. (1997) · Blood · doi:10.1182/blood.v90.11.4341 · Cited by 115
Self-citationCacalano, N. A., Migone, T., Bazán, F., Hanson, E. P., Chen, M., Candotti, F., O’Shea, J. J., & Johnston, J. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1549 · Cited by 115
A dual role for the kinase-like domain of the tyrosine kinase Tyk2 in interferon-α signaling
Yeh, T. C., Dondi, E., Uzé, G., & Pellegrini, S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160130297 · Cited by 111
Liu, K. D., Gaffen, S. L., Goldsmith, M. A., & Greene, W. C. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00369-1 · Cited by 103
Richter, M. F., Duménil, G., Uzé, G., Fellous, M., & Pellegrini, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.38.24723 · Cited by 96
Novel Role of Janus Kinase 1 in the Regulation of Oncostatin M Receptor Surface Expression
Radtke, S., Hermanns, H. M., Haan, C., de Leur, H. S.-V., Heinrich, P. C., Behrmann, I., & Gascan, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m100822200 · Cited by 90
Slíva, D., Wood, T. J., Schindler, C., Lobie, P. E., & Norstedt, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47180-3 · Cited by 80
Haan, C., Heinrich, P. C., & Behrmann, I. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3610105 · Cited by 71
Al‐Lazikani, B., Sheinerman, F. B., & Honig, B. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011577898 · Cited by 67
Orientational Constraints of the gp130 Intracellular Juxtamembrane Domain for Signaling
Greiser, J. S., Stroß, C., Heinrich, P. C., Behrmann, I., & Hermanns, H. M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204113200 · Cited by 59
Computational and functional analysis of the putative SH2 domain in Janus Kinases.
Kampa, D., & Burnside, J. (2000) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.2000.3757 · Cited by 56
Cited by
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
Baxter, E. J., Scott, L. M., Campbell, P. J., East, C., Fourouclas, N., Swanton, S., Vassiliou, G. S., Bench, A. J., Boyd, E. M., Curtin, N., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71142-9 · Cited by 3,548
A Gain-of-Function Mutation of JAK2 in Myeloproliferative Disorders
Kralovics, R., Passamonti, F., Buser, A. S., Teo, S.-S., Tiedt, R., Passweg, J. R., Tichelli, A., Cazzola, M., & Skoda, R. C. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051113 · Cited by 3,470
The Pseudokinase MLKL Mediates Necroptosis via a Molecular Switch Mechanism
Murphy, J. M., Czabotar, P. E., Hildebrand, J. M., Lucet, I. S., Zhang, J.-G., Alvarez-Diaz, S., Lewis, R., Lalaoui, N., Metcalf, D., Webb, A. I., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.06.018 · Cited by 1,220
“Pseudokinases comprise 10% of mammalian kinomes and have emerged as regulators of cell signaling, acting predominantly as modulators of bona fide protein kinases (Boudeau et al., 2006; Saharinen and Silvennoinen, 2002; Zeqiraj and van Aalten, 2010).”
BackgroundJanus kinases in immune cell signaling
Ghoreschi, K., Laurence, A., & O’Shea, J. J. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00754.x · Cited by 1,149
The molecular details of cytokine signaling via the JAK/STAT pathway
Morris, R., Kershaw, N. J., & Babon, J. J. (2018) · Protein Science · doi:10.1002/pro.3519 · Cited by 943
Metadata
- Authors
- Saharinen, P., & Silvennoinen, O.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-12
- Volume
- 277
- Issue
- 49
- Pages
- 47954-47963
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2006795381
- Cited by
- 318
- References
- 50
- FWCI
- 3.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.